title: Bevacizumab use in disseminated choroid plexus papilloma.
authors.forename: Mark Daniel
authors.initials: MD
authors.lastname: Anderson
authors.forename: Brett J
authors.initials: BJ
authors.lastname: Theeler
authors.forename: Marta
authors.initials: M
authors.lastname: Penas-Prado
authors.forename: Morris D
authors.initials: MD
authors.lastname: Groves
authors.forename: W K Alfred
authors.initials: WK
authors.lastname: Yung
mesh_terms: D000328:Adult; D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D000068258:Bevacizumab; D001921:Brain / Q000473:pathology; D006801:Humans; D008159:Lumbar Vertebrae; D008297:Male; D008875:Middle Aged; D059408:Pain Management / Q000379:methods; D020288:Papilloma, Choroid Plexus / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery; D013116:Spinal Cord / Q000473:pathology
chemical_list: D020533:Angiogenesis Inhibitors; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab